Skip to main content
. 2018 Nov 12;8:16699. doi: 10.1038/s41598-018-35139-3

Figure 4.

Figure 4

MiR-33a-5p and miR-128-3p could be used to distinguish early-stage lung cancer patients from healthy controls. MiR-33a-5p (A) and miR-128-3p (C) were down-regulated in early lung cancer patients (TNM stage I-II) compared to healthy controls (P < 0.001). The ROC analysis for detection of early lung cancer patients from health controls using miR-33a-5p (B), miR-128-3p (D), and miR-33a-5p + miR-128-3p (E). (F) The comparison of diagnostic values between miR-33a-5p, miR-128-3p and the combination. ***P < 0.001.